[1]
E. M. Ibrahim, A. A. Refae, A. M. Bayer, N. Abdullah, and M. E. Al-Foheidi, “Adjuvant Therapy Benefits for Patients With Human Epidermal Growth Factor Receptor 2-Positive T1aN0M0 Breast Cancer: A Systematic Review and Meta-Analysis”, World J Oncol, vol. 16, no. 3, pp. 276–285, Jun. 2025, doi: 10.14740/wjon2578.